Resistance Training for Cardiometabolic Health
(OVERCOME-IT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new home-based resistance training program to determine its effects on heart and metabolic health. Researchers aim to assess whether participants find the program easy to use and beneficial. They seek Black or African American women who have not engaged in much resistance training and have conditions such as being overweight, prediabetes, or high blood pressure. Participants must have a device like a smartphone or computer to access the program. As an unphased trial, participants contribute to valuable research that may lead to better health solutions for their community.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, especially since the trial includes people taking medications for conditions like hypertension and diabetes.
What prior data suggests that this resistance training program is safe?
Research has shown that online resistance training exercises are safe and easy for most people. One study found that this type of exercise program not only ensures safety but also improves health in individuals with medical conditions, indicating that people generally manage it well without major issues.
Another study found that online training helps individuals maintain their exercise routines. This finding is important because it demonstrates that the program can be both safe and enjoyable. Overall, evidence suggests that resistance training from home is a safe way to exercise.12345Why are researchers excited about this trial?
Researchers are excited about this remotely delivered resistance training because it offers a unique way to improve cardiometabolic health without the need for in-person gym sessions. Unlike traditional exercise programs that require physical attendance, this method is accessible from home through a web-based platform, making it convenient and adaptable to individual schedules. This approach could potentially increase adherence and consistency, which are crucial for effective health improvements. Additionally, by leveraging digital technology, it can provide personalized guidance and support, enhancing the overall effectiveness of the training.
What evidence suggests that this remotely delivered resistance training is effective for cardiometabolic health?
Research has shown that strength training can greatly improve heart and metabolic health. Studies have found that strength exercises can help lower body weight and reduce fat. This trial will evaluate a home-based resistance training program delivered through a web-based platform. Training at home, especially when paired with a healthy diet, can also enhance heart and metabolic health. Additionally, strength training programs delivered through smartphones have proven effective, particularly for older adults. These findings suggest that remote strength training could be a promising way to boost overall health.34678
Who Is on the Research Team?
Amber W Kinsey, PhD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for Black or African American women aged 30-64 who are not regularly doing resistance training and have conditions like overweight, obesity, prediabetes, diabetes, or hypertension. Participants must live near the University, be willing to exercise at home using an internet-connected device and get medical clearance if needed.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a remotely delivered resistance training program via a web-based platform
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Remotely Delivered Resistance Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator